S Braune-Stefan

Bernauer Str. 12
Prien Am Chiemsee, BY 83209, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry.

Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry.

Journal: Neurology and therapy

Published: December 17, 2024

Accuracy of MSBase criteria to diagnose secondary progressive multiple sclerosis in large German real-world patient cohort.

Accuracy of MSBase criteria to diagnose secondary progressive multiple sclerosis in large German real-world patient cohort.

Journal: Multiple sclerosis and related disorders

Published: May 06, 2024

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry.

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry.

Journal: BMC neurology

Published: February 24, 2023

Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.

Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis.

Journal: BMC medical research methodology

Published: January 31, 2019

Letter to the editor on "Multiple sclerosis registries in Europe - An updated mapping survey" published in Multiple Sclerosis and Related Disorder 27 (2019) 171-178.

Letter to the editor on "Multiple sclerosis registries in Europe - An updated mapping survey" published in Multiple Sclerosis and Related Disorder 27 (2019) 171-178.

Journal: Multiple sclerosis and related disorders

Published: November 30, 2018

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry.

Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry.

Journal: Journal of neurology

Published: May 08, 2018

Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.

Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.

Journal: Clinical autonomic research : official journal of the Clinical Autonomic Research Society

Published: January 13, 2018

Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.

Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.

Journal: Journal of neurology

Published: August 16, 2015

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.

Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.

Journal: Journal of neurology

Published: May 30, 2013

Evidence-based pharmacotherapy of neuropathic pain syndromes

Evidence-based pharmacotherapy of neuropathic pain syndromes

Journal: MMW Fortschritte der Medizin

Published: January 22, 2005

Showing 1-10 of 10

Last Updated: 09/26/2026